Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib Regimens in t(4;14) Positive Multiple Myeloma
NCT00570180Phase 2Completed
- Sponsor
- University Health Network
- Start
- Aug 2008
- Primary completion
- Sep 2015
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by University Health Network. Started Aug 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00570180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570180.